Redhawk Wealth Advisors Inc. Grows Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Redhawk Wealth Advisors Inc. grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 13.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,378 shares of the company’s stock after acquiring an additional 764 shares during the period. Redhawk Wealth Advisors Inc.’s holdings in Cardinal Health were worth $754,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in CAH. State Street Corp raised its position in Cardinal Health by 4.6% in the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after purchasing an additional 627,253 shares during the period. Geode Capital Management LLC grew its stake in shares of Cardinal Health by 0.7% in the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after buying an additional 42,082 shares in the last quarter. Pacer Advisors Inc. raised its holdings in shares of Cardinal Health by 4.7% during the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock valued at $474,203,000 after buying an additional 191,568 shares during the period. ProShare Advisors LLC boosted its holdings in Cardinal Health by 5.1% in the 2nd quarter. ProShare Advisors LLC now owns 1,759,299 shares of the company’s stock worth $172,974,000 after acquiring an additional 85,247 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in Cardinal Health by 2.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after acquiring an additional 33,388 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on CAH shares. Citigroup boosted their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research report on Friday, January 10th. Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and upped their price objective for the company from $132.00 to $145.00 in a research report on Monday, January 6th. Wells Fargo & Company raised Cardinal Health from an “underweight” rating to an “equal weight” rating and lifted their target price for the stock from $101.00 to $127.00 in a research report on Friday, December 13th. Barclays increased their price target on Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Finally, Mizuho assumed coverage on Cardinal Health in a report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $133.29.

Cardinal Health Trading Up 1.9 %

CAH stock opened at $127.03 on Friday. The firm has a market cap of $30.74 billion, a P/E ratio of 24.71, a P/E/G ratio of 1.48 and a beta of 0.63. The stock’s 50 day simple moving average is $120.46 and its 200 day simple moving average is $111.50. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $127.08.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The company had revenue of $52.28 billion for the quarter, compared to the consensus estimate of $50.90 billion. During the same period last year, the firm posted $1.73 EPS. The company’s revenue for the quarter was down 4.3% on a year-over-year basis. On average, research analysts forecast that Cardinal Health, Inc. will post 7.82 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. The ex-dividend date was Thursday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.